Literature DB >> 4812394

Vitamin A, pregnancy, and oral contraceptives.

J Wild, C J Schorah, R W Smithells.   

Abstract

It has been shown that women receiving oral contraceptives have increased levels of serum vitamin A. High vitamin A levels may constitute a teratogenic hazard and it has been suggested that women who conceive soon after discontinuing oral contraceptive therapy may be especially at risk to this hazard.We have confirmed a significant increase in vitamin A levels in women taking oral contraceptives. During early pregnancy there is no significant difference in vitamin A levels between women who have recently been taking oral contraceptives and those who have not. We have been unable to show that either taking oral contraceptives shortly before pregnancy or a high vitamin A level during the first trimester of pregnancy, comparable to that of a woman taking oral contraceptives, has any detrimental effect on the outcome of pregnancy. It seems unlikely that women who conceive soon after discontinuing oral contraception run any teratogenic risk from increased vitamin A levels.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4812394      PMCID: PMC1632878          DOI: 10.1136/bmj.1.5897.57

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  10 in total

1.  CHRONIC HYPERVITAMINOSIS A. REPORT OF A CASE IN AN ADULT.

Authors:  J SOLER-BECHARA; J L SOSCIA
Journal:  Arch Intern Med       Date:  1963-10

2.  Congenital anomalies in the rat produced by excessive intake of vitamin A during pregnancy.

Authors:  S Q COHLAN
Journal:  Pediatrics       Date:  1954-06       Impact factor: 7.124

3.  The Vanderbilt cooperative study of maternal and infant nutrition. IV. Dietary, laboratory and physical findings in 2,129 delivered pregnancies.

Authors:  W J DARBY; W J McGANITY; M P MARTIN; E BRIDGFORT; P M DENSEN; M M KASER; P J OGLE; J A NEWBILL; A STOCKELL; M E FERGUSON; O TOUSTER; G S McCLELLAN; C WILLIAMS; R O CANNON
Journal:  J Nutr       Date:  1953-12-10       Impact factor: 4.798

4.  THE CONCENTRATION OF VITAMIN A IN THE BLOOD PLASMA DURING PREGNANCY.

Authors:  O Bodansky; J M Lewis; M C Lillienfeld
Journal:  J Clin Invest       Date:  1943-09       Impact factor: 14.808

5.  Some effects of oral contraceptives on carbohydrate metabolism.

Authors:  V Wynn; J W Doar
Journal:  Lancet       Date:  1966-10-01       Impact factor: 79.321

6.  Fluorometric determination of vitamin A in human blood and liver.

Authors:  J N Thompson; P Erdody; R Brien; T K Murray
Journal:  Biochem Med       Date:  1971-02

7.  Serum lipids and lipoproteins during long-term administration of an oral contraceptive.

Authors:  M Aurell; K Cramér; G Rybo
Journal:  Lancet       Date:  1966-02-05       Impact factor: 79.321

8.  [Hypervitaminosis A in pregnancy and neonatal malformations of the urinary tract].

Authors:  G Pilotti; A Scorta
Journal:  Minerva Ginecol       Date:  1965-11-30

9.  Retinol-binding protein: the transport protein for vitamin A in human plasma.

Authors:  M Kanai; A Raz; D S Goodman
Journal:  J Clin Invest       Date:  1968-09       Impact factor: 14.808

10.  Effects of oral contraceptives on human plasma vitamin-A levels.

Authors:  I Gal; C Parkinson; I Craft
Journal:  Br Med J       Date:  1971-05-22
  10 in total
  5 in total

Review 1.  The pathophysiology and clinical aspects of hypercalcemic disorders.

Authors:  D B Lee; E T Zawada; C R Kleeman
Journal:  West J Med       Date:  1978-10

Review 2.  [Metabolic studies under administration of oral contraceptives. A review].

Authors:  S Hauschildt
Journal:  Z Ernahrungswiss       Date:  1978-03

Review 3.  Influence of sex on drug kinetics in man.

Authors:  J F Giudicelli; J P Tillement
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

4.  Letter: Vitamin A and the teratogenic risks of oral contraceptives.

Authors:  M H Briggs
Journal:  Br Med J       Date:  1974-07-20

5.  Vitamin deficiencies and neural tube defects.

Authors:  R W Smithells; S Sheppard; C J Schorah
Journal:  Arch Dis Child       Date:  1976-12       Impact factor: 3.791

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.